We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$70B
AUM Growth
+$9.17B
Cap. Flow
+$1.72B
Cap. Flow %
2.45%
Top 10 Hldgs %
24.19%
Holding
1,743
New
270
Increased
557
Reduced
362
Closed
215

Top Sells

Rank Stock Value
1
NTES icon
NetEase
NTES
+$470M
2
KSU
Kansas City Southern
KSU
+$278M
3
ETN icon
Eaton
ETN
+$269M
4
PHI icon
PLDT
PHI
+$195M
5
BUD icon
AB InBev
BUD
+$143M

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Healthcare 15.85%
3 Financials 13.41%
4 Industrials 13.3%
5 Communication Services 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AORT icon
1101
Artivion
AORT
$1.3B
$21K ﹤0.01%
793
+265
+50% +$6.51K
CNXN icon
1102
PC Connection
CNXN
$2.11B
$21K ﹤0.01%
439
CROX icon
1103
Crocs
CROX
$6.14B
$21K ﹤0.01%
+525
New +$18.3K
EFX icon
1104
Equifax
EFX
$20.3B
$21K ﹤0.01%
+155
New +$21.5K
SPXC icon
1105
SPX Corp
SPXC
$11B
$21K ﹤0.01%
427
TT icon
1106
Trane Technologies
TT
$100B
$21K ﹤0.01%
158
-10,108
-98% -$1.28M
XNCR icon
1107
Xencor
XNCR
$1.5B
$21K ﹤0.01%
634
+204
+47% +$7.45K
PENG
1108
Penguin Solutions Inc
PENG
$2.7B
$21K ﹤0.01%
1,110
+822
+285% +$12.7K
ROIC
1109
DELISTED
Retail Opportunity Investments Corp.
ROIC
$21K ﹤0.01%
1,194
+571
+92% +$10.3K
VIVO
1110
DELISTED
Meridian Bioscience Inc
VIVO
$21K ﹤0.01%
2,152
+197
+10% +$1.85K
RDUS
1111
DELISTED
Radius Health, Inc.
RDUS
$21K ﹤0.01%
1,071
+372
+53% +$9.03K
AGEN
1112
Agenus
AGEN
$312M
$20K ﹤0.01%
+263
New +$17.6K
CME icon
1113
CME Group
CME
$96.3B
$20K ﹤0.01%
100
EBF icon
1114
Ennis
EBF
$552M
$20K ﹤0.01%
942
+263
+39% +$5.35K
FBNC icon
1115
First Bancorp
FBNC
$2.6B
$20K ﹤0.01%
+525
New +$20.1K
JBGS
1116
JBG SMITH
JBGS
$818M
$20K ﹤0.01%
+519
New +$20.5K
KAI icon
1117
Kadant
KAI
$3.63B
$20K ﹤0.01%
+197
New +$18.7K
NWE icon
1118
NorthWestern Energy
NWE
$4.23B
$20K ﹤0.01%
284
PLPC icon
1119
Preformed Line Products
PLPC
$1.75B
$20K ﹤0.01%
341
TCBK icon
1120
TriCo Bancshares
TCBK
$1.84B
$20K ﹤0.01%
+510
New +$19.4K
TKR icon
1121
Timken Company
TKR
$9.56B
$20K ﹤0.01%
357
WLY icon
1122
John Wiley & Sons Class A
WLY
$2.65B
$20K ﹤0.01%
+424
New +$19.7K
IBKC
1123
DELISTED
IBERIABANK Corp
IBKC
$20K ﹤0.01%
272
KNL
1124
DELISTED
Knoll, Inc.
KNL
$20K ﹤0.01%
814
AGRO icon
1125
Adecoagro
AGRO
$1.44B
$19K ﹤0.01%
2,354
+2,222
+1,683% +$14.9K

Similar funds

Lazard Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Lazard Asset Management held 1,743 positions worth $70B, up 15% from $60.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lazard Asset Management's Q4 2019 filing shows 270 new, 557 increased, 362 reduced and 215 closed positions. Its largest new stake was West Pharmaceutical: 89,164 shares worth $13.4M. The largest sale was NetEase, an estimated $470M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Lazard Asset Management's largest Q4 2019 buy was West Pharmaceutical: 89,164 shares worth $13.4M.
  • Lazard Asset Management added most to McDonald's in Q4 2019, an estimated $575M increase.
  • Lazard Asset Management's biggest Q4 2019 reduction was NetEase, cutting an estimated $470M.
  • Lazard Asset Management fully exited Corelogic, Inc. in Q4 2019, selling an estimated $68.4M.
  • Lazard Asset Management's ten largest holdings make up 24% of its $70B portfolio in Q4 2019.
  • Lazard Asset Management opened 270 new positions and closed 215 in Q4 2019.
  • Lazard Asset Management's portfolio value rose 15% quarter-over-quarter to $70B.

Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.